Recent Finacing
Recent Raise
A company that develops disease-specific immune modulators using a proprietary NanoDisc antigen-delivery platform to restore immune tolerance, advancing therapies for multiple autoimmune indications (MOG-antibody disease, T1D, celiac, RA, lupus).
